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Confident Diagnosis of Bronchobiliary
Fistula Using Contrast-Enhanced
Magnetic Resonance Cholangiography
We report the utility of contrast-enhanced magnetic resonance cholangiogra-
phy (MRC) using gadoxetic acid (Gd-EOB-DTPA) in the diagnosis of bronchobil-
iary fistula associated with liver hydatid cyst. Contrast-enhanced MRC clearly
delineated the leakage of contrast agent from the biliary duct and its communica-
tion with the bronchial tree. Providing functional information about physiologic or
pathologic biliary flow in addition to the display of biliary anatomy, contrast-
enhanced MRC stands as a robust technique in confidently detecting bronchobil-
iary fistula and bile leaks.
ronchobiliary fistula (BBF) is an unusual disorder characterized by an
abnormal communication between the biliary tract and the bronchial
tree. It can develop as a complication of hepatic surgery and interven-
tions, or can be associated with various hepatobiliary diseases such as hydatid disease,
hepatic abscesses, liver metastases, biliary lithiasis, and acute cholecystitis (1-6). 
Although history of bilioptysis is pathognomonic for BBF, imaging tests are often
required to verify the diagnosis and to demonstrate the site of communication along
with underlying disease and associated findings. Endoscopic retrograde cholangiopan-
creatography (ERCP), computed tomography (CT), magnetic resonance cholangiogra-
phy (MRC), and hepatobiliary scintigraphy are the most commonly employed imaging
modalities (1-3). MRC is a safe and non-invasive technique demonstrating biliary
anatomy and providing information for treatment planning, whether endoscopic,
percutaneous, or surgical (1, 2). Contrast-enhanced (CE) MRC using hepatobiliary
contrast agents is a recently emerged technique with promising results with respect to
its ability to visualize non-dilated bile ducts and biliary leaks (7-9). However, the use
of CE-MRC in the detection of BBF has not been reported previously. We present the
performance and utility of CE-MRC using gadoxetic acid (Gd-EOB-DTPA) in the
comprehensive evaluation of bronchobiliary fistula developed secondary to a hydatid
cyst.
CASE REPORT
A 56-year-old woman presented with a persistent cough and expectoration of a
copious amount of greenish material consistent with biliary secretions (bilioptysis). Her
complaints had started after a cholecystectomy nine months previously. A degener-
ated hydatid cyst was discovered in the dome of her liver during surgery. Laboratory
findings were within normal limits other than slightly elevated lactate dehydrogenase
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BA chest radiograph showed right paracardiac infiltrates
and a subsequent chest CT revealed mild stenosis in right
middle lobe bronchus associated with distal subsegmental
atelectasis and air bronchograms (Fig. 1A). Also present
was an obscure hypodense lesion containing several
punctate calcifications measuring 3 cm in liver segment 8
on CT (Fig. 1B). The lesion was extending anteriorly in the
subdiaphragmatic region adjacent to the inferior surface of
the right middle lobe. The continuity of diaphragm was
interrupted at this location. Conventional and CE-MRC
were performed using an 8-channel phased-array body coil
on a 1.5T scanner (Signa Excite HD; General Electric,
Milwaukee, WI). A conventional T2-weighted MRC
demonstrated stenosis of the common bile duct as well as a
biliary fistula extending to a subphrenic liver cyst, which
communicated with the bronchial tree (Fig. 1C). To distin-
guish the communication between the biliary and
bronchial tree, a CE-MRC was performed using breath-
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Fig. 1. Bronchobiliary fistula in 56-year-old woman.
A. Chest CT shows distal subsegmental atelectasis and air bronchograms in right middle lobe. 
B. Targeted coronal reconstruction of upper abdominal CT shows obscure subdiaphragmatic hypodense lesion (arrows) adjacent to
inferior surface of right middle lobe.
C. Coronal 3D-maximum intensity projection reconstruction of conventional MR cholangiography demonstrates stenosis of common bile
duct (arrows) as well as fistulous bronchobiliary communication. 
D. Coronal 3D-maximum intensity projection reconstruction of contrast-enhanced MR cholangiography reveals contrast agent leaking
from ventrocranial branch of right hepatic duct and further into subphrenic liver cyst (arrowheads), which transdiaphragmatically
communicates with bronchial tree. Stricture of common bile duct is also demonstrated (arrows). 
CDhold transverse and coronal 3-dimensional (3D) fat-
suppressed gradient echo (LAVA, liver acquisition
volumetric acceleration); (TR/TE, 4/1.8 milliseconds; flip
angle, 12 degrees; section thickness, 3 mm; signal averages,
1; matrix, 288×192; scan time, 28 seconds) images,
acquired 30 minutes after the intravenous administration
of 25 μ mol/kg gadolinium-ethoxybenzyl-diethylenetri-
amine pentaacetic acid (Gd-EOB-DTPA, gadoxetic acid;
Primovist, Bayer Schering Pharma, Berlin, Germany). In
the hepatobiliary phase images, a stricture of the common
bile duct was seen. Moreover, contrast agent was seen
concretely leaking from the ventrocranial branch of the
right hepatic duct as well as into the subphrenic liver cyst
and further transdiaphragmatically communicating with
the bronchial tree (Fig. 1D). A biliary stent was placed
endoscopically to close the fistula and to bridge the biliary
stricture. The patient’s symptoms were diminished after a
successful biliary decompression.
DISCUSSION
Bronchobiliary fistula is an extremely rare clinical
condition in which a bile leak penetrates the diaphragm
into the bronchial tree, more frequently on the right side.
In our case, transdiaphragmatic extension may likely have
been caused by permeation of subdiaphragmatic inflamma-
tion as a result of a degenerated hydatid cyst. However,
since the patient’s complaints began after a cholecystec-
tomy, a surgical injury with subsequent stenosis of the
common bile duct might also be a contributory factor.
Bronchobiliary fistula may lead to a variety of
pulmonary complications including recurrent chemical and
bacterial pneumonitis, bronchiolitis, bronchiectasis, and
mediastinitis. Diagnosing a BBF is conducted based on the
clinical symptom of bilioptysis (bile-stained sputum) (1-5).
CT is the first line imaging technique for the investigation
of the chest and upper abdomen. Although it rarely depicts
the BBF, it may provide indirect findings such as
subphrenic fluid collection, discontinuity of the diaphragm,
bronchiectasis, atelectasis, or a pleural effusion (1-6). In
our case, CT showed stenosis of the right middle lobe
bronchus associated with distal atelectasis and bronchiecta-
sis. Adjacent to right middle lobe was a hypodense lesion
with punctuate calcification in the dome of the liver with
obscuration of the diaphragm.
For patients with BBF, invasive procedures such as a
percutaneous transhepatic cholangiography or ERCP have
traditionally been performed in order to display the biliary
anatomy. Conventional MRC performed without the use
of contrast material is a rapid, safe, and non-invasive
technique displaying the biliary tree. Moreover, it has been
shown to be useful in the detection of BBF, and other
biliary leaks; however, it lacks functional information (1, 2,
10). Therefore, conventional MRC only demonstrates
indirect proof of bile leakage rather than directly depicting
it. Another limitation of the technique is the inability to
differentiate bile leaks from ascites as well as other
perihepatic fluid collections. CE-MRC using hepatobiliary
contrast agents is a recently developed technique that
provides a combination of anatomic and functional
information. It is particularly helpful in the concrete
documentation of bile leaks since it directly depicts biliary
excretion from injured ducts (9). Nevertheless, the use of
CE-MRC in the comprehensive evaluation of bronchobil-
iary fistula has not been reported previously.
Currently, three hepatobiliary contrast agents are
available for CE-MRC: mangafodipir trisodium (Mn-
DPDP; Teslascan; GE Healthcare, Oslo, Norway), gadobe-
nate dimeglumine (Gd-BOPTA; MultiHance, Bracco
Imaging, Milan, Italy), and gadolinium-ethoxybenzyl-
diethylenetriamine pentaacetic acid (Gd-EOB-DTPA,
gadoxetic acid; Primovist, Bayer Schering Pharma, Berlin,
Germany). Both gadobenate dimeglumine and Gd-EOB-
DTPA are incorporated into the hepatocytes by an anionic
transport system after the vascular phase. Approximately
3-5% of the injected dose of gadobenate dimeglumine,
and 50% of Gd-EOB-DTPA are excreted in the human
biliary system (8, 11). The earlier onset (10-20 min) and
longer duration (2 hours) of a high degree of contrast
between the biliary system and liver for Gd-EOB-DTPA
provides adequate hepatobiliary imaging within a shorter
time span than Gd-BOPTA (8). In our case, a conventional
T2-weighted MRC demonstrated possible communication
between the subphrenic liver cyst and the bronchial tree.
On the other hand, CE-MRC clearly delineated the leakage
of contrast agent from the ventrocranial branch of the right
hepatic duct into subphrenic liver cyst as well as the
transdiaphragmatic communication with the bronchial tree.
A stricture of the common bile duct was depicted for both
techniques. In addition to adequate anatomic display, CE-
MRC also provides functional information similar to a
99mTc-HIDA scintigraphy. Thus, it can reliably differentiate
bile leaks from other fluid collections such as ascites or
seroma.
Treatment of BBF requires the removal of distal obstruc-
tion, reduction of flow through the fistula, or excision of
the fistula. Nonoperative radiologic and gastrointestinal
interventions via external and internal stenting reduce
biliary obstruction and they should be the first therapeutic
option in the management of BBF. Operative approaches
should be reserved only when interventional procedures
fail, or in patients with advanced concurrent diseases. In
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successful biliary decompression by biliary stent
placement. 
In conclusion, Gd-EOB-DTPA enhanced upper abdomi-
nal MRI using 3D gradient echo techniques provides a
robust tool for the visualization of the biliary tree in the
hepatobiliary phase. Not only does CE-MRC display the
biliary anatomy, it also provides functional information
about physiologic or pathologic biliary flow. These proper-
ties make it an invaluable tool in the accurate detection of
bronchobiliary fistula and bile leaks.
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